Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
31,93%
5-year Growth Rate
R
6/6
5-year Risk Analysis
O
12,45%
Outlook 12/26
W
65,16%
Margin of safety
T
21,94%
Analyst Price Target
H
UP
50-week EMA Trend
Company Info
EPS Growth 5Y
29,27%
Revenue growth 5Y
34,43%
Price growth 5Y
-68,10%
Market Cap
HK$155,12 B
Long-Term Debt
HK$0,19 B
Quarterly earnings
08/20/2026
Dividend
HK$0,00
Dividend Yield
0,00%
Industry
Country
Website
ISIN Number
WuXi Biologics (Cayman) Price Chart (HKD)
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
HK$47,24
21.94%
Last Update: 07/27/2026
Analysts: 23
Highest Price Target HK$78,50
Average Price Target HK$47,24
Lowest Price Target HK$30,61
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
WuXi Biologics (Cayman)
SEHK:2269
|
-68,10% | -68,10% | 0,00% | 31,93% | 6/6 | 12,45% | 65,16% | 24,97% | UP |
